Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Retinoic metabolism inhibitors promising against prostate cancer

July 2, 2004

Exelixis submits IND for XL-999

July 2, 2004

FDA accepts IND for MN-029

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Alimta receives positive opinion in Europe

July 1, 2004

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

July 1, 2004

Preliminary data on Exherin in patients with solid tumors

July 1, 2004

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

July 1, 2004

Palifermin NDA submitted for oral mucositis

July 1, 2004

Preclinical progress in DOS-47 development program

June 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...